9/11/26 07:30 | 9/9/26 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P.m | 828 | 4.14 | 0 | 200 | 15 | 1,500 | D | | | | | | | | | | | | | | |
12/16/25 09:30 | 12/15/25 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P.d | 113 | 4.12 | 0 | 28 | 2 | 1,300 | D | | | | | | | | | | | | | | |
11/6/25 07:30 | 11/5/25 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P | 600 | 2.20 | 0 | 273 | 27 | 1,273 | D | | | | | | | | | | | | | | |
8/28/25 16:56 | 8/26/25 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P.m | 178 | 0.6696 | 0 | 266 | 36 | 1,000 | D | | | | | | | | | | | | | | |
5/20/25 18:01 | 5/16/25 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P.m | 175 | 0.4992 | 0 | 350 | 91 | 734 | D | | | | | | | | | | | | | | |
9/11/24 17:47 | 9/9/24 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P.m | 395 | 2.82 | 0 | 140 | 57 | 384 | D | | | | | | | | | | | | | | |
1/31/24 18:29 | 1/29/24 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P.m | 387 | 3.87 | 0 | 100 | 69 | 244 | D | | | | | | | | | | | | | | |